Related Experiment Video
Updated: Jun 8, 2026
Assay for Adhesion and Agar Invasion in S. cerevisiae
Published on: November 8, 2006
Sphingolipid signaling in fungal pathogens
Ryan Rhome1, Maurizio Del Poeta
1Department of Biochemistry and Molecular Biology, Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Abstract:
Sphingolipid involvement in infectious disease is a new and exciting branch of research. Various microbial pathogens have been shown to synthesize their own sphingolipids and some have evolved methods to "hijack" host sphingolipids for their own use. For instance, Sphingomonas species are bacterial pathogens that lack the lipopolysaccharide component typical but instead contain glycosphingolipids (Kawahara 1991, 2006). In terms of sphingolipid signaling and function, perhaps the best-studied group of microbes is the pathogenic fungi. Pathogenic fungi still represent significant problems in human disease, despite treatments that have been used for decades. Because fungi are eukaryotic, drug targets in fungi can have many similarities to mammalian processes. This often leads to significant side effects of antifungal drugs that can be dose limiting in many patient populations. The search for fungal-specific drugs and the need for better understanding of cellular processes of pathogenic fungi has led to a large body of research on fungal signaling. One particularly interesting and rapidly growing field in this research is the involvement of fungal sphingolipid pathways in signaling and virulence. In this chapter, the research relating to sphingolipid signaling pathogenic fungi will be reviewed and summarized, in addition to highlighting pathways that show promise for future research.
Insights
Microbial pathogens, including fungi, utilize sphingolipids for survival and virulence. Understanding fungal sphingolipid pathways is crucial for developing targeted antifungal drugs with fewer side effects.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Sphingolipids play critical roles in microbial pathogenesis, with some pathogens synthesizing their own or hijacking host sphingolipids.
- Pathogenic fungi, despite existing treatments, remain a significant threat to human health.
- Eukaryotic similarities between fungi and mammals complicate antifungal drug development, often leading to dose-limiting side effects.
Purpose of the Study:
- To review and summarize research on sphingolipid signaling in pathogenic fungi.
- To highlight fungal sphingolipid pathways involved in virulence and signaling.
- To identify promising avenues for future research in antifungal drug development.
Main Methods:
- Literature review and synthesis of existing research on fungal sphingolipid pathways.
- Analysis of sphingolipid synthesis and signaling mechanisms in pathogenic fungi.
- Identification of potential drug targets within fungal sphingolipid metabolism.
Main Results:
- Sphingolipid pathways are integral to fungal virulence and cellular processes.
- Microbial pathogens, including bacteria like Sphingomonas, interact with host sphingolipids.
- Fungal sphingolipid signaling pathways offer potential targets for novel antifungal therapies.
Conclusions:
- Sphingolipid research in pathogenic fungi is a rapidly growing field with significant therapeutic potential.
- Targeting fungal-specific sphingolipid pathways could lead to more effective and safer antifungal treatments.
- Further investigation into fungal sphingolipid signaling is warranted for advancing infectious disease research.
Related Concept Videos
01:28Yeast Signaling
01:15Antifungal Agents
01:28Fungal Phylum Microsporidia
01:17Gene Regulation During Sporulation
01:28Gene Regulation in Microbial Communities: Quorum Sensing
01:09Microbe-Plant Interactions